Summary

A new-generation device used in the treatment of transcatheter closure of congenital heart defects provides easier delivery, better septal apposition, and faster endothelialization than an older version of the device. Early clinical experience showed the device to be efficient and successful in closing both atrial septal defects and patent foramen ovales.